Cleared Traditional

K925155 - OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT

K925155 is an FDA 510(k) clearance for OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT, manufactured by Olympus Corp.. The device is a Class 2 Chemistry device with product code CIT cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K925155 · Olympus Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1993
Decision
105d
Days
Class 2
Risk

K925155 is an FDA 510(k) clearance for the OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Olympus Corp. (Lake Success, US). The FDA issued a Cleared decision on January 26, 1993 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Olympus Corp. devices

FDA 510(k) Submission Details - K925155

510(k) Number K925155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 1992
Decision Date January 26, 1993
Days to Decision 105 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 88d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CIT Device Classification - Class 2, Special Controls

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 133
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K925155.
KODAK EKTACHEM CLINICAL CHEMISTRY SLIDE FOR ASPARATE AMIMOTRANSFERASE
K934413 · Eastman Kodak Company · Apr 1994
ASPARTATE AMINOTRANSFERASE (AST) TEST
K935181 · Em Diagnostic Systems, Inc. · Jan 1994
STANBIO AST/GOT (LIQUI-UV) TEST SET, CAT NO. 9020
K932049 · Stanbio Laboratory · Nov 1993
ROCHE REAGENT FOR AST
K924244 · Roche Diagnostic Systems, Inc. · Jan 1993
AST (GOT) - ASPARTATE AMINOTRANSFERASE
K923505 · Randox Laboratories, Ltd. · Nov 1992
IL TEST AST, PN 35312
K923641 · Instrumentation Laboratory CO · Oct 1992